Frontlight ResearchEarly access
Trial site
Hospital de Clínicas de Ribeirão Preto
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Obesity2 trials
- Asthma1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Stroke1 trial
- Thyroid cancer1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Loxo Oncology, Inc.2 trials
- University of Calgary1 trial
Running trials
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Asthma1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Crohn's disease1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026